BiotechTube
Home/InMed Pharmaceuticals/Michael Woudenberg
MW

Michael Woudenberg

Vice President, CMC

InMed Pharmaceuticals

Therapeutic Areas

DermatologyOphthalmology

InMed Pharmaceuticals Pipeline

DrugIndicationPhase
INM-755Epidermolysis Bullosa (wound care)Phase 2
INM-088GlaucomaPreclinical

Leadership Team at InMed Pharmaceuticals

EA
Eric A. Adams
President, CEO & Director
BS
Bruce S. Colwill
Chief Financial Officer
AD
Alexandra D.J. Mancini
Senior Vice President, Clinical & Regulatory Affairs
SE
S. Eric Innis
Chief Medical Officer
View full InMed Pharmaceuticals profile